Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) made progress on its pivotal PARADIGM Trial during the June quarter, enrolling and treating its first US patients after securing Medicare ...

Completed enrollment of MIST global Phase 2b trial of AP01 with 398 patients; topline data expected in the second half of 2027Two abstracts ...

The financial results for Anteris for the quarter ended June 30, 2026, are presented below. All amounts in $ refer to U.S. dollars.

June quarter report shows that the US rollout of its Wise leadless pacemaker device is gaining momentum, even though the process has not been without its challenges.

Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to ...

STATEN ISLAND, N.Y., Aug. 12, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small ...

When war changes, schools change. New technology, the politics of mass mobilization and campaign design, and novel tactics that defined Napoleonic warfare led to Gerhard von Scharnhorst’s reforms and ...

"John has shaped the science behind our platform for years, and his foundational work is central to how we think about recovery," said Zach Henderson, CEO of MindMaze Therapeutics. "As we scale in the ...

Legend Biotech is transitioning from a capital-intensive biotech to a profitable, CARVYKTI-driven commercial cell therapy company. Q2 results highlight 52% YoY revenue growth, strong international ...

The West Monroe–West Ouachita Chamber of Commerce announced it is promoting an upcoming regional workshop designed to equip ...

Thank you. Good day and thank you for standing by. Welcome to the Absci Second Quarter Business Update. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...

You’re reading The TNR Blue Book. Get daily scoops, strategy, and developments inside the liberal ideas factory delivered right to your inbox. Sign up for free. Inside Washington The big question in ...